BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30399590)

  • 1. NK cells in cerebral ischemia.
    Chen C; Ai QD; Chu SF; Zhang Z; Chen NH
    Biomed Pharmacother; 2019 Jan; 109():547-554. PubMed ID: 30399590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buyang Huanwu Decoction Attenuates Infiltration of Natural Killer Cells and Protects Against Ischemic Brain Injury.
    Dou B; Zhou W; Li S; Wang L; Wu X; Li Y; Guan H; Wang C; Zhu S; Ke Z; Huang C; Wang Z
    Cell Physiol Biochem; 2018; 50(4):1286-1300. PubMed ID: 30355926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia.
    Jin WN; Ducruet AF; Liu Q; Shi SX; Waters M; Zou M; Sheth KN; Gonzales R; Shi FD
    FASEB J; 2018 May; 32(5):2757-2767. PubMed ID: 29401578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice.
    Zechariah A; ElAli A; Hermann DM
    Stroke; 2010 May; 41(5):1008-12. PubMed ID: 20360548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity.
    Li M; Li Z; Yao Y; Jin WN; Wood K; Liu Q; Shi FD; Hao J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E396-E405. PubMed ID: 27994144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke.
    Winklewski PJ; Radkowski M; Demkow U
    J Neuroinflammation; 2014 Dec; 11():213. PubMed ID: 25539803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis.
    Doeppner TR; Mlynarczuk-Bialy I; Kuckelkorn U; Kaltwasser B; Herz J; Hasan MR; Hermann DM; Bähr M
    Brain; 2012 Nov; 135(Pt 11):3282-97. PubMed ID: 23169919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats.
    Bake S; Okoreeh AK; Alaniz RC; Sohrabji F
    Endocrinology; 2016 Jan; 157(1):61-9. PubMed ID: 26556536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic neurons recruit natural killer cells that accelerate brain infarction.
    Gan Y; Liu Q; Wu W; Yin JX; Bai XF; Shen R; Wang Y; Chen J; La Cava A; Poursine-Laurent J; Yokoyama W; Shi FD
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2704-9. PubMed ID: 24550298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
    Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of microRNA-210 suppresses pro-inflammatory response and reduces acute brain injury of ischemic stroke in mice.
    Huang L; Ma Q; Li Y; Li B; Zhang L
    Exp Neurol; 2018 Feb; 300():41-50. PubMed ID: 29111308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
    Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y
    J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.